ZFYVE27 Gene SPG33 Genetic Test sale cost 4400 AED
KCNQ3 Gene Seizures Benign Neonatal Type 2 Genetic Test sale cost 4400 AED KCNQ3 Gene Seizures Benign Neonatal Type 2 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
VPS37A Gene SPG53 Genetic Test sale cost 4400 AED VPS37A Gene SPG53 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

ZFYVE27 Gene SPG33 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ZFYVE27 Gene SPG33 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the ZFYVE27 gene, which are linked to the development of spastic paraplegia 33 (SPG33), a rare form of hereditary spastic paraplegia. This condition is characterized by progressive stiffness and contraction in the lower limbs, affecting mobility and daily activities. The test involves analyzing the patient’s DNA to detect any genetic anomalies associated with SPG33, providing crucial information for diagnosis, management, and family planning.

Conducted at DNA Labs UAE, a leading facility in genetic testing, this test is available for a cost of 4400 AED. DNA Labs UAE employs state-of-the-art technology and highly qualified professionals to ensure accurate and reliable results. By opting for the ZFYVE27 Gene SPG33 Genetic Test, patients and their families can gain valuable insights into their genetic health, paving the way for tailored treatment plans and informed decisions about their future.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ZFYVE27 Gene SPG33 Genetic Test

Components

  • Price: 4400.0 AED

Sample Condition

Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery

3 to 4 Weeks

Method

NGS Technology

Test Type

Neurological Disorders

Doctor

Neurologist

Test Department

Genetics

Pre Test Information

Clinical History of Patient who is going for ZFYVE27 Gene SPG33 NGS Genetic DNA Test

A Genetic Counselling session to draw a pedigree chart of family members affected with ZFYVE27 Gene SPG33

Test Details

The ZFYVE27 gene is associated with a rare neurological disorder called hereditary spastic paraplegia type 33 (SPG33). This disorder is characterized by progressive muscle stiffness and weakness in the lower limbs, leading to difficulty walking and often requiring the use of a wheelchair.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of SPG33, NGS genetic testing can be used to identify mutations or variations in the ZFYVE27 gene that may be causing the disorder. This can help with the diagnosis of SPG33 and provide information about the underlying genetic cause of the condition.

NGS genetic testing for SPG33 typically involves obtaining a DNA sample, usually through a blood sample or a cheek swab. The DNA is then sequenced using NGS technology to analyze the ZFYVE27 gene and other relevant genes associated with hereditary spastic paraplegia.

The results of the test can help confirm a diagnosis, provide information about the genetic cause of the disorder, and may also have implications for family members who may be at risk of inheriting the condition.

It is important to note that genetic testing for SPG33 is typically done in specialized genetic testing laboratories and requires a healthcare provider’s referral. Genetic counseling is often recommended before and after testing to discuss the implications of the test results and provide support and guidance to individuals and families affected by SPG33.

Test Name ZFYVE27 Gene SPG33 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ZFYVE27 Gene SPG33 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ZFYVE27 Gene SPG33
Test Details

The ZFYVE27 gene is associated with a rare neurological disorder called hereditary spastic paraplegia type 33 (SPG33). This disorder is characterized by progressive muscle stiffness and weakness in the lower limbs, leading to difficulty walking and often requiring the use of a wheelchair.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of SPG33, NGS genetic testing can be used to identify mutations or variations in the ZFYVE27 gene that may be causing the disorder. This can help with the diagnosis of SPG33 and provide information about the underlying genetic cause of the condition.

NGS genetic testing for SPG33 typically involves obtaining a DNA sample, usually through a blood sample or a cheek swab. The DNA is then sequenced using NGS technology to analyze the ZFYVE27 gene and other relevant genes associated with hereditary spastic paraplegia. The results of the test can help confirm a diagnosis, provide information about the genetic cause of the disorder, and may also have implications for family members who may be at risk of inheriting the condition.

It is important to note that genetic testing for SPG33 is typically done in specialized genetic testing laboratories and requires a healthcare provider’s referral. Genetic counseling is often recommended before and after testing to discuss the implications of the test results and provide support and guidance to individuals and families affected by SPG33.

SKU: TEST-2002 Category:

Related products